Description What critical problem/question will researchers try to answer? For far too long, drug development for neuroendocrine carcinomas has attempted to adapt approaches from non-neuroendocrine carcinomas from the same tumor site. Instead, we propose a successful path toward drug development would focus on features unique to neuroendocrine carcinomas and that these features can serve as … Continue reading Tumor cell surface targeting of high-grade neuroendocrine carcinomas